Literature DB >> 15076749

Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity.

Yun Xu1, Yuan-Xiang Tao.   

Abstract

Platelet-activating factor (PAF), a bioactive phospholipid implicated in neuronal excitotoxic death, augments the presynaptic release of glutamate. Excessive activation of postsynaptic glutamate receptors and subsequent downstream signals leads to excitotoxicity. The present study proposed that the NMDA receptor/nitric oxide (NO) signal pathway might be involved in PAF-induced neurotoxicity. After the cultured neurons were exposed to PAF for 24 h the percentage of neuronal death increased in a dose-dependent manner. The PAF effects were significantly prevented not only by BN52021, a PAF antagonist, but also by MK-801, an NMDA antagonist, and L-NAME, an NO synthase (NOS) inhibitor. Moreover, the increases in NOS activity and neuronal NOS expression induced by chronic exposure of the cultured neurons to PAF were dramatically blocked by BN52021 and MK-801, respectively. Our findings suggest that the NMDA receptor/NO signaling pathway might contribute to the pathological mechanism of cell death triggered via PAF receptor activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076749     DOI: 10.1097/00001756-200402090-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection.

Authors:  Yun Xu; Wenri Zhang; Judith Klaus; Jennifer Young; Ines Koerner; Laird C Sheldahl; Patricia D Hurn; Francisco Martínez-Murillo; Nabil J Alkayed
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

2.  PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment.

Authors:  Yuan-Xiang Tao; Roger A Johns
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

3.  Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.

Authors:  Matthew J Bellizzi; Shao-Ming Lu; Eliezer Masliah; Harris A Gelbard
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

4.  Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist.

Authors:  Wen-Chao Liu; Wen-Long Ding; Hong-Yu Gu; Ming-Feng Chen; Jin-Jia Hu
Journal:  Neurosci Bull       Date:  2007-09       Impact factor: 5.203

Review 5.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

6.  Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.

Authors:  Anja Boetkjaer; Merete Boedker; Jian-Guo Cui; Yuhai Zhao; Walter J Lukiw
Journal:  Neurosci Lett       Date:  2007-08-31       Impact factor: 3.046

7.  NMDA receptor dependent PGC-1alpha up-regulation protects the cortical neuron against oxygen-glucose deprivation/reperfusion injury.

Authors:  Yun Luo; Wenjing Zhu; Jia Jia; Chenyu Zhang; Yun Xu
Journal:  J Mol Neurosci       Date:  2009-04-03       Impact factor: 3.444

Review 8.  Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.

Authors:  Matthew J Bellizzi; Shao-Ming Lu; Harris A Gelbard
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

9.  Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.

Authors:  Nathan B Erdmann; Nick P Whitney; Jialin Zheng
Journal:  Clin Neurosci Res       Date:  2006-12

10.  Postsynaptic density-93 deficiency protects cultured cortical neurons from N-methyl-D-aspartate receptor-triggered neurotoxicity.

Authors:  M Zhang; J T Xu; X Zhu; Z Wang; X Zhao; Z Hua; Y X Tao; Y Xu
Journal:  Neuroscience       Date:  2010-01-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.